Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback